1
|
Neto EDS, Pedro PPDA, Cartágenes MDSDS, Neto JOB, Garcia JBS. The effect of low dose intra-articular S(+) ketamine on osteoarthritis in rats: an experimental study. Braz J Anesthesiol 2024; 74:844502. [PMID: 38604407 PMCID: PMC11031719 DOI: 10.1016/j.bjane.2024.844502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 02/16/2024] [Accepted: 03/04/2024] [Indexed: 04/13/2024]
Abstract
BACKGROUND This study aimed to investigate the analgesic impact of S(+)-ketamine on pain behavior and synovial inflammation in an osteoarthritis (OA) model. METHODS Animals were grouped as follows: OA-Saline (n = 24) and OA-Ketamine (n = 24), OA induced via intra-articular sodium monoiodoacetate (MIA); a Non-OA group (n = 24) served as the control. On the 7th day post OA induction, animals received either saline or S(+)-ketamine (0.5 mg.kg-1). Behavioral and histopathological assessments were conducted up to day 28. RESULTS S(+)-ketamine reduced allodynia from day 7 to 28 and hyperalgesia from day 10 to 28. It notably alleviated weight distribution deficits from day 10 until the end of the study. Significant walking improvement was observed on day 14 in S(+)-ketamine-treated rats. Starting on day 14, OA groups showed grip force decline, which was countered by S(+)-ketamine on day 21. However, S(+)-ketamine did not diminish synovial inflammation. CONCLUSION Low Intra-articular (IA) doses of S(+)-ketamine reduced MIA-induced OA pain but did not reverse synovial histopathological changes. IRB APPROVAL NUMBER 23115 012030/2009-05.
Collapse
Affiliation(s)
| | | | - Maria do Socorro de Sousa Cartágenes
- Universidade Federal do Maranhão, Departamento de Ciências Fisiológicas; Universidade Federal do Maranhão, Laboratório Experimental para Estudo da Dor, São Luiz, MA, Brazil; Faculdade de Medicina da Universidade Ceuma, São Luiz, MA, Brazil
| | - José Osvaldo Barbosa Neto
- Universidade Federal do Maranhão, Laboratório Experimental para Estudo da Dor, São Luiz, MA, Brazil; Faculdade de Medicina da Universidade Ceuma, São Luiz, MA, Brazil.
| | - João Batista Santos Garcia
- Universidade Federal do Maranhão, Laboratório Experimental para Estudo da Dor, São Luiz, MA, Brazil; Universidade Federal do Maranhão, Departamento de Anestesiologia, Dor e Paliativos, São Luiz, MA, Brazil
| |
Collapse
|
2
|
Santiago LÂM, Ataíde ACS, de Araújo Morais D, da Silva Lima A, Dos Santos Martins N, Dourado AVCA, Ribeiro RM, Lima-Neto LG, de Sá Sousa JC, da Rocha CQ, de Sousa Cartágenes MDS, Carvalho RC, de Sousa EM. Bixa orellana ethyl acetate fraction and its isolated compound ellagic acid attenuate the progression of MIA-induced osteoarthritis in rat knees. Biomed Pharmacother 2023; 168:115644. [PMID: 37839112 DOI: 10.1016/j.biopha.2023.115644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2023] [Revised: 09/26/2023] [Accepted: 10/03/2023] [Indexed: 10/17/2023] Open
Abstract
Osteoarthritis (OA) is a pathology that is characterized by progressive erosion of articular cartilage. In this context, medicinal plants have become relevant tools regarding their potential role in the prevention and treatment of OA, being safe and effective. The aim of this work was investigate the therapeutic efficacy of the ethyl acetate fraction of Bixa orellana leaves (BoEA) and ellagic acid (ElAc) for the therapeutic treatment of OA induced by monosodium iodoacetate (MIA) in rats. The plant material was extracted via maceration with 70 % hydroalcoholic solvent (BoHE). The ethyl acetate (BoEA) fraction was by solvents in increasing order of polarity. The ElAc was identified and isolated in BoEA using high performance liquid chromatography (HPLC-DAD) and analytical curve. The OA was induced using MIA in the right knee at the knee joint. Doses of BoEA and ElAc were administered daily (every 24 h, orally) at concentrations of 50, 100 and 50 mg/kg, respectively, for 28 days after induced OA. We evaluated the animals through clinical and radiological examinations every 7 days and, on the 29th day, the animals were euthanized, the joints being removed for histopathological analysis and the serum for cytokine analysis. BoEA and ElAc compounds reduced inflammation and nociception in OA and were as effective as indomethacin in clinical parameters of joint discomfort and allodynia in rats, in addition to showing improvements in radiological and histopathological images, acting on the progress of cartilage deterioration, proving properties related to anti-inflammatory and analgesic processes, being important allies for new therapeutic interventions for the treatment of OA.
Collapse
Affiliation(s)
- Luis Ângelo Macêdo Santiago
- Graduate Program in Biodiversity and Biotechnology of the Bionorte Network, - BIONORTE - Federal University of Maranhão, Maranhão-UFMA, São Luis 65080-805, Brazil.
| | | | - Danilo de Araújo Morais
- Graduate Program in Microbial Biology, CEUMA University-UniCEUMA, São Luís 65075-120, Brazil
| | - Aldilene da Silva Lima
- Graduate Program in Chemistry, Federal University of Maranhão-UFMA, São Luis 65080-805, Brazil
| | | | | | - Rachel Melo Ribeiro
- Graduate Program in Health Sciences - Federal University of Maranhão-UFMA, São Luis 65080-805, Brazil
| | - Lídio Gonçalves Lima-Neto
- Graduate Program in Biodiversity and Biotechnology of the Bionorte Network, - BIONORTE - Federal University of Maranhão, Maranhão-UFMA, São Luis 65080-805, Brazil; Graduate Program in Microbial Biology, CEUMA University-UniCEUMA, São Luís 65075-120, Brazil
| | | | | | | | - Rafael Cardoso Carvalho
- Graduate Program in Health Sciences - Federal University of Maranhão-UFMA, São Luis 65080-805, Brazil
| | - Eduardo Martins de Sousa
- Graduate Program in Biodiversity and Biotechnology of the Bionorte Network, - BIONORTE - Federal University of Maranhão, Maranhão-UFMA, São Luis 65080-805, Brazil; Graduate Program in Health Sciences - Federal University of Maranhão-UFMA, São Luis 65080-805, Brazil; Graduate Program in Microbial Biology, CEUMA University-UniCEUMA, São Luís 65075-120, Brazil
| |
Collapse
|
3
|
Rodrigues CFDA, Rodrigues TA, de Oliveira EJSG, Garcia JBS, Cartágenes MDSDS. Prejudice impairing quality of life in sickle cell disease patients in a developing country: faces of suffering. Hematol Transfus Cell Ther 2023; 45 Suppl 2:S3-S10. [PMID: 34294599 PMCID: PMC10433304 DOI: 10.1016/j.htct.2021.06.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 05/17/2021] [Accepted: 06/13/2021] [Indexed: 11/27/2022] Open
Abstract
INTRODUCTION The perception of prejudice against, and stigmatization of, sickle cell disease (SCD) leads the patient to perceive a different treatment, due to the disease stigma and may be related to a worse quality of life (QoL). OBJECTIVES Describe and evaluate the perception of the prejudice against the disease and its impact on the quality of life of patients with sickle cell disease. METHODS This is a cross-sectional study conducted between March 2019 and February 2020, with patients diagnosed with SCD. Patients were questioned about the perception of prejudice in any kind of situation, choosing between "Yes" or "No", not differentiating situations related to prejudice. To assess the QoL and impact of the disease, the volunteers answered a version of the SF-36 questionnaire translated and validated into Brazilian Portuguese. RESULTS In this study, 113 patients with SCD were followed up, 92% were classified as HbSS and the rest, divided between HbSC and HbS-β-0. Regarding the SF-36, the worst scores were in the summary of the physical components (mean 48.19 ± 21.51) and the physical aspect had the lowest mean (30.75 ±€42.65). When questioned if they had already perceived any kind of prejudice, including the SCD, 32.74% answered "Yes". For this comparison, there was a significant difference in the summary of the physical and mental components, with worse QoL for those who had already suffered prejudice. CONCLUSION Patients diagnosed with SCD who reported perception of prejudice had statistically significant worse QoL, revealing the negative impact, that might lead to sadness and social isolation.
Collapse
Affiliation(s)
| | - Thiago Alves Rodrigues
- Centro de Ciências Biológicas e da Saúde, Universidade Federal Universal do Maranhão (CCBS UFMA), São Luís, MA, Brazil
| | | | - João Batista Santos Garcia
- Centro de Ciências Biológicas e da Saúde, Universidade Federal Universal do Maranhão (CCBS UFMA), São Luís, MA, Brazil
| | | |
Collapse
|
4
|
de Morais SV, Mendonça PG, Vasconcelos CC, Lopes PLA, Garcia JBS, Calzerra NTM, de Queiroz TM, Lima STDJRM, Silva GEB, Lopes AJO, Cartágenes MDSDS, Domingues GRDS. Cuminaldehyde Effects in a MIA-Induced Experimental Model Osteoarthritis in Rat Knees. Metabolites 2023; 13:397. [PMID: 36984837 PMCID: PMC10056807 DOI: 10.3390/metabo13030397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Revised: 03/01/2023] [Accepted: 03/07/2023] [Indexed: 03/30/2023] Open
Abstract
Osteoarthritis (OA) is a chronic degenerative disease that has a significant global impact. It is associated with aging and characterized by widespread joint destruction. Cuminaldehyde is a biologically active component of essential oils that has shown promise in the treatment of nociceptive and inflammatory diseases. This study investigated the effects of cuminaldehyde on an experimental model of osteoarthritis induced in rat knees. Cuminaldehyde was found to be as effective as indomethacin in reducing pain in all evaluated tests, including forced walking, functional disability of weight distribution on the legs, and spontaneous pain in animals with osteoarthritis. The knees of animals treated with cuminaldehyde had significantly higher radiographic and histopathological scores than those of animals that did not receive the treatment. Cuminaldehyde also modulated the production of pro-inflammatory cytokines. In vitro assays showed that cuminaldehyde preferentially inhibits COX-2 enzyme activity. In silico studies demonstrated that cuminaldehyde has satisfactory energy affinity parameters with opioid receptors and COX-2. These findings suggest that cuminaldehyde's anti-inflammatory activity is multifactorial, acting through multiple pathways. Its nociceptive activity occurs via central and peripheral mechanisms. Cuminaldehyde modulates the immune response of the inflammatory process and may be considered a leading compound for the development of new anti-inflammatory and analgesic drugs.
Collapse
Affiliation(s)
- Sebastião Vieira de Morais
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil
| | - Priscylla Gouveia Mendonça
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil
| | - Cleydlenne Costa Vasconcelos
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil
| | - Paloma Larissa Arruda Lopes
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil
| | - João Batista Santos Garcia
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil
| | - Natalia Tabosa Machado Calzerra
- Department of Physiology and Pharmacology, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235—Cidade Universitária, Recife 50670-901, PE, Brazil
| | - Thyago Moreira de Queiroz
- Laboratory of Nutrition, Physical Activity and Phenotypic Plasticity, Federal University of Pernambuco, Av. Prof. Moraes Rego, 1235—Cidade Universitária, Recife 50670-901, PE, Brazil
| | | | - Gyl Eanes Barros Silva
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís 65085-580, MA, Brazil
- Hospital Universitário Presidente Dutra, HUPD, Federal University of Maranhão, R. Barão de Itapari, 227—Centro, São Luís 65020-070, MA, Brazil
| | - Alberto Jorge Oliveira Lopes
- Federal Institute of Science Education and Technology of Maranhão—Campus Monte Castelo, Chemistry Postgraduate Program, Av. Getúlio Vargas, 04—Monte Castelo, São Luís 65030-005, MA, Brazil
| | | | - Gerson Ricardo de Souza Domingues
- State University of Rio de Janeiro School of Medicine, Av. Prof. Manoel de Abreu, 444, Vila Isabel—Rio de Janeiro 20550-170, RJ, Brazil
| |
Collapse
|
5
|
da Silva AF, Farias JR, Franco DCG, Galiza AA, Motta EP, Oliveira ADS, Vasconcelos CC, Cartágenes MDSDS, da Rocha CQ, da Silva MCP, Lopes AJO, do Nascimento FRF, Monteiro CA, Guerra RNM. Anti- Candida albicans Activity of Ononin and Other Secondary Metabolites from Platonia Insignis MART. Metabolites 2022; 12:1014. [PMID: 36355097 PMCID: PMC9696916 DOI: 10.3390/metabo12111014] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2022] [Revised: 10/13/2022] [Accepted: 10/19/2022] [Indexed: 12/01/2023] Open
Abstract
Candida albicans is a human pathogen that is part of the healthy microbiome. However, it is often associated with opportunistic fungal infections. The treatment of these infections is challenging because prolonged exposure to antifungal drugs can culminate in fungal resistance during therapy, and there is a limited number of available drugs. Therefore, this study investigated the antifungal activity of ononin by in silico and in vitro assays, and in Tenebrio molitor as an alternative in vivo model of infection caused by C. albicans. Ononin is an isoflavone glycoside derived from formononetin that has various biological activities. According in silico evaluation, ononin showed the best electron affinity in molecular docking with CaCYP51, with a binding free energy of -10.89 kcal/mol, superior to that of the antifungal drugs fluconazole and posaconazole. The ononin + CaCYP51 complex formed hydrogen bonds with Tyr132, Ser378, Phe380, and Met508, as well as hydrophobic connections with Tyr118, Leu121, Phe126, Leu131, Ile304, and Leu309, and interactions with the heme group. Ononin exerted anti-Candida albicans activity, with MIC between 3.9 and 7.8 µg/mL, and inhibited young and mature biofilms, with a reduction in cell density and metabolic activity of 50 to 80%. The compound was not cytotoxic to sheep red blood cells at concentrations up to 1000 µg/mL. Larvae of the mealworm T. molitor were used as an alternative in vivo model of C. albicans infection. Ononin was able to prolong larval survival at concentrations of 0.5, 1, and 5 mg/kg, and was not toxic up to a concentration of 20 mg/kg. Moreover, ononin reduced the fungal charge in treated animals. In conclusion, our results suggest that ononin has anti-Candida albicans activity and is a potential candidate for the development of new therapeutic alternatives.
Collapse
Affiliation(s)
- Anderson França da Silva
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Biotechnology-RENORBIO, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Josivan Regis Farias
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Danielle Cristine Gomes Franco
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Andrea Araruna Galiza
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Biotechnology-RENORBIO, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Elizangela Pestana Motta
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Aluísio da Silva Oliveira
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | | | - Maria do Socorro de Sousa Cartágenes
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
- Laboratory of Experimental Study of Pain, Department of Physiological Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | | | - Mayara Cristina Pinto da Silva
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Alberto Jorge Oliveira Lopes
- Federal Institute of Science Education and Technology of Maranhão-Campus Santa Inês, Santa Inês 65300-000, Brazil
| | - Flavia Raquel Fernandes do Nascimento
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| | - Cristina Andrade Monteiro
- Department of Biology, Federal Institute of Science Education and Technology of Maranhão, São Luís 65030-005, Brazil
| | - Rosane Nassar Meireles Guerra
- Laboratory of Immunophysiolgy, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Biotechnology-RENORBIO, Federal University of Maranhão, São Luís 65080-805, Brazil
- Program in Health Sciences, Federal University of Maranhão, São Luís 65080-805, Brazil
| |
Collapse
|
6
|
Santiago LÂM, Neto RNM, Santos Ataíde AC, Fonseca DCSC, Soares EFA, de Sá Sousa JC, Mondego-Oliveira R, Ribeiro RM, de Sousa Cartágenes MDS, Lima-Neto LG, Carvalho RC, de Sousa EM. Flavonoids, alkaloids and saponins: are these plant-derived compounds an alternative to the treatment of rheumatoid arthritis? A literature review. Clin Phytosci 2021. [DOI: 10.1186/s40816-021-00291-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
AbstractRheumatoid arthritis (RA) is a systemic inflammatory disease characterized by synovial inflammation leading to progressive joint erosion and, eventually, joint deformities. RA treatment includes anti-inflammatories, corticosteroids, synthetic disease-modifying antirheumatic drugs (DMARDs), and immunosuppressants. Drug administration is associated with adverse reactions, as gastrointestinal ulcers, cardiovascular complications, and opportunistic infections. Wherefore, different plant-derived phytochemical compounds are studied like new therapeutic approach to treatment of RA. Among the phytochemical compounds of plants for treatment of RA, flavonoids, alkaloids and saponins are related for present anti-inflammatory activity and act as physiological and metabolic regulators. They have low toxicity compared to other active plant compounds, so their therapeutic properties are widely studied. The intention of the review is to present an overview of the therapeutics of flavonoids, alkaloids, and saponins for RA. An extensive literature survey was undertaken through different online platforms:PubMed, SciELO, and Virtual Health Library databases, to identify phytochemical compounds used in RA treatment and the descriptors used were medicinal plants, herbal medicines, and rheumatoid arthritis. Seventy-five research and review articles were found to be apt for inclusion into the review. The present study summarizes the phytochemicals isolated from plants that have therapeutic effects on RA models, in vitro and in vivo. The studied substances exerted anti-inflammatory, chondroprotective, immunoregulatory, anti-angiogenic, and antioxidant activities and the most compounds possess good therapeutic properties, valuable for further research for treatment of RA.
Collapse
|
7
|
Vasconcelos CC, Lopes AJO, de Jesus Garcia Ataide E, Carvalho KWP, de Brito MFF, Rodrigues MS, de Morais SV, Silva GEB, da Rocha CQ, Garcia JBS, de Sousa Cartágenes MDS. Arrabidaea chica Verlot fractions reduce MIA-induced osteoarthritis progression in rat knees. Inflammopharmacology 2021; 29:735-752. [PMID: 33881683 DOI: 10.1007/s10787-021-00803-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Accepted: 03/15/2021] [Indexed: 10/21/2022]
Abstract
This study aims to investigate the activity of n-hexane, ethyl acetate and butanol fractions obtained from Arrabidaea chica Verlot against MIA-induced osteoarthritis (OA). The antinociceptive potentials of each fraction were evaluated through a cyclooxygenase (COX) 1 and 2 inhibition test and an in vivo OA-model. In addition, toxicity assessments in the liver, spleen and kidney, as well as radiographic and histopathological knee analyses, were performed. The chemical composition of the n-hexane fraction was elucidated, and a molecular docking protocol was carried out to identify which compounds are associated with the detected bioactivity. The n-hexane A. chica fraction preferentially inhibits COX-2, with 90% inhibition observed at 10 µg/mL. The fractions also produced significant improvements in OA incapacity, motor activity and hyperalgesia parameters and in radiological knee conditions. However, concerning the histopathological evaluations, these improvements were only significant in the hexane and ethyl acetate fraction treatments, which resulted in better average scores, suggesting that these fractions slow OA-promoted joint injury progression. Histopathological organ analyses indicate that the fractions are not toxic to animals. Twenty compounds were identified in the n-hexane fraction, comprising fatty acids, terpenes and phytosterols. In silico analyses indicate the presence of favourable interactions between some of the identified compounds and the COX-2 enzyme, mainly concerning alpha-tocopherol (Vitamin E), squalene and beta-sitosterol. The findings indicate that A. chica fractions display analgesic, anti-inflammatory properties, are non-toxic and are able to slow OA progression, and may, therefore, be prioritized as natural products in OA human clinical trials.
Collapse
Affiliation(s)
- Cleydlenne Costa Vasconcelos
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil.
| | - Alberto Jorge Oliveira Lopes
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil
| | - Emilly de Jesus Garcia Ataide
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil
| | - Kevin Waquim Pessoa Carvalho
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil
| | | | - Marineide Sodré Rodrigues
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil
| | - Sebastião Vieira de Morais
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil
| | - Gyl Eanes Barros Silva
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil.,Hospital Universitário Presidente Dutra, HUPD, Federal University of Maranhão, São Luís, MA, Brazil
| | | | - João Batista Santos Garcia
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA, 65085-580, Brazil
| | | |
Collapse
|
8
|
Barboza JR, Pereira FAN, Fernandes RA, Vasconcelos CC, Cartágenes MDSDS, Oliveira Lopes AJ, de Melo AC, Guimarães IDS, da Rocha CQ, Ribeiro MNDS. Cytotoxicity and Pro-Apoptotic, Antioxidant and Anti-Inflammatory Activities of Geopropolis Produced by the Stingless Bee Melipona fasciculata Smith. Biology (Basel) 2020; 9:biology9090292. [PMID: 32942772 PMCID: PMC7566010 DOI: 10.3390/biology9090292] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 09/08/2020] [Accepted: 09/09/2020] [Indexed: 12/11/2022]
Abstract
Geopropolis is produced by some stingless bee species, such as Melipona fasciculata Smith, a native species from Brazil. This study aims to investigate the antioxidant and anti-inflammatory activities and cytotoxicity effects of geopropolis hydroethanolic extracts against lung (H460 and A549) and ovarian (A2780 and ES2) cancer cell lines and non-tumor (HUVEC) cell lines using chemical identification by LC/MS/MS analysis and in silico assays to determine which compounds are associated with bioactivity. The antioxidant activity of extracts and inhibitory activity against COX enzymes were assessed by in vitro assays; cytotoxicity effect was evaluated by the MTT assay; cell cycle was assessed by flow cytometry and apoptosis by Western blotting. The geopropolis extracts showed great radical scavenging potential, preferential inhibition of COX-2, decreased cancer cell viability, non-cytotoxic effects against the non-tumoral cell line, besides modulating the cell cycle and inducing cancer cell apoptosis through the activation of caspase-3 and PARP protein cleavage. The in silico study suggests that corilagin, typhaneoside, taraxerone and marsformosanone, identified by LC/MS/MS, can be associated with anti-inflammatory activity and cytotoxic effects. Thus, the current study suggests the potential of geopropolis concerning the research field of new pharmacological alternatives regarding cancer therapy.
Collapse
Affiliation(s)
- Josianne Rocha Barboza
- Laboratório de Farmacognosia, Departamento de Farmácia, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (F.A.N.P.); (A.J.O.L.); (M.N.d.S.R.)
- Correspondence: (J.R.B.); (C.Q.d.R.); Tel.: +55-98-3272-9243 (C.Q.d.R.)
| | - Francisco Assis Nascimento Pereira
- Laboratório de Farmacognosia, Departamento de Farmácia, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (F.A.N.P.); (A.J.O.L.); (M.N.d.S.R.)
| | - Renan Amphilophio Fernandes
- Programa de Pós-Graduação em Farmacologia e Química Medicinal, Instituto de Ciências Biológicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21041-250, Rio de Janeiro, Brazil;
| | - Cleydlenne Costa Vasconcelos
- Laboratório de Estudo Experimental da Dor, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (C.C.V.); (M.d.S.d.S.C.)
| | - Maria do Socorro de Sousa Cartágenes
- Laboratório de Estudo Experimental da Dor, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (C.C.V.); (M.d.S.d.S.C.)
| | - Alberto Jorge Oliveira Lopes
- Laboratório de Farmacognosia, Departamento de Farmácia, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (F.A.N.P.); (A.J.O.L.); (M.N.d.S.R.)
- Laboratório de Estudo Experimental da Dor, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (C.C.V.); (M.d.S.d.S.C.)
| | - Andreia Cristina de Melo
- Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rua André Cavalcanti, 37, Rio de Janeiro 20231-050, Rio de Janeiro, Brazil; (A.C.d.M.); (I.d.S.G.)
| | - Isabella dos Santos Guimarães
- Divisão de Pesquisa Clínica e Desenvolvimento Tecnológico, Instituto Nacional de Câncer, Rua André Cavalcanti, 37, Rio de Janeiro 20231-050, Rio de Janeiro, Brazil; (A.C.d.M.); (I.d.S.G.)
| | - Cláudia Quintino da Rocha
- Laboratório de Química de Produtos Naturais, Departamento de Química, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil
- Correspondence: (J.R.B.); (C.Q.d.R.); Tel.: +55-98-3272-9243 (C.Q.d.R.)
| | - Maria Nilce de Sousa Ribeiro
- Laboratório de Farmacognosia, Departamento de Farmácia, Campus Bacanga, Universidade Federal do Maranhão, Av. dos Portugueses, 1966, São Luís 65080-805, Maranhão, Brazil; (F.A.N.P.); (A.J.O.L.); (M.N.d.S.R.)
| |
Collapse
|
9
|
Lima MVV, Freire ADO, Sousa ELF, Vale AAM, Lopes AJO, Vasconcelos CC, Lima-Aragão MVV, Serra HO, Liberio RNMG, dos Santos APSDA, Silva GEB, da Rocha CQ, Moreira Lima FCV, Cartágenes MDSDS, Garcia JBS. Therapeutic Use of Scoparia dulcis Reduces the Progression of Experimental Osteoarthritis. Molecules 2019; 24:molecules24193474. [PMID: 31557835 PMCID: PMC6803828 DOI: 10.3390/molecules24193474] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2019] [Revised: 09/07/2019] [Accepted: 09/10/2019] [Indexed: 11/20/2022] Open
Abstract
Pain is recognized as one of the main symptoms in knee osteoarthritis and is the main reason why patients seek medical attention. Scoparia dulcis has been popularly used to relieve discomfort caused by various painful conditions. The objective of the study is to evaluate the analgesic and anti-inflammatory effect of the crude extract of S. dulcis, in an experimental model of osteoarthritis. The experiment was performed with Wistar rats divided into 4 groups with 5 animals each: healthy, saline, crude extract, and meloxicam groups. Knee osteoarthritis was induced by intra-articular injection of sodium mono-iodoacetate. First, clinical parameters of pain were assessed at days 0, 5, 10, 15, and 20 after induction. Second, the potential cyclooxygenase inhibition was evaluated, and the cytokines of the synovial fluid were quantified. An in silico test and Molecular Docking tests were performed. A histopathological evaluation was made on articular cartilage with safranin O staining. The results showed that a 15-day treatment with crude extract reduced edema, spontaneous pain, peripheral nociceptive activity, and proinflammatory cytokines in the synovial fluid. The highest inhibition of cyclooxygenase 2 in the crude extract occurred at 50 µg/mL. The crude extract of S. dulcis presents therapeutic potential for the treatment of osteoarthritis due to its anti-inflammatory and anti-nociceptive action.
Collapse
Affiliation(s)
- Marcus Vinícius Viégas Lima
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
- Universidade Ceuma, São Luís 65075-120, Brazil
- Correspondence: (M.V.V.L.); (M.d.S.d.S.C.); (J.B.S.G.); Tel.: +55-(98)-3272-9527 (M.V.V.L.)
| | - Abner de Oliveira Freire
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | - Emerson Lucas Frazão Sousa
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | - André Alvares Marques Vale
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | - Alberto Jorge Oliveira Lopes
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
- Universidade Federal do Maranhão, Coordenação de Ciências Naturais, Campus Bacabal, São Luís 65080-80, Brazil
| | - Cleydlenne Costa Vasconcelos
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | - Mônica Virginia Viégas Lima-Aragão
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | | | - Rosane Nassar Meireles Guerra Liberio
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | - Ana Paula Silva de Azevedo dos Santos
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
| | - Gyl Eanes Barros Silva
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
- Hospital Universitário Presidente Dutra, São Luís 65020-070, Brazil;
| | | | | | - Maria do Socorro de Sousa Cartágenes
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
- Correspondence: (M.V.V.L.); (M.d.S.d.S.C.); (J.B.S.G.); Tel.: +55-(98)-3272-9527 (M.V.V.L.)
| | - João Batista Santos Garcia
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís 65080-805, Brazil; (A.d.O.F.); (E.L.F.S.); (A.A.M.V.); (A.J.O.L.); (C.C.V.); (R.N.M.G.L.); (A.P.S.d.A.d.S.); (G.E.B.S.)
- Correspondence: (M.V.V.L.); (M.d.S.d.S.C.); (J.B.S.G.); Tel.: +55-(98)-3272-9527 (M.V.V.L.)
| |
Collapse
|
10
|
Vasconcelos CC, Lopes AJO, Sousa ELF, Camelo DS, Lima FCVM, Rocha CQD, Silva GEB, Garcia JBS, Cartágenes MDSDS. Effects of Extract of Arrabidaea chica Verlot on an Experimental Model of Osteoarthritis. Int J Mol Sci 2019; 20:E4717. [PMID: 31547612 PMCID: PMC6801924 DOI: 10.3390/ijms20194717] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 09/13/2019] [Accepted: 09/18/2019] [Indexed: 02/06/2023] Open
Abstract
The aim of this study was to analyze the analgesic potential of Arrabidaea chica extract (EHA) as an alternative to osteoarthritis (OA) treatment. Thus, the extract was initially evaluated by the cyclooxygenase inhibition test. The analgesic effect of the extract, in vivo, was also verified in a model of OA induced by sodium monoiodoacetate (2 mg). EHA was administered to rats at doses of 50, 150, and 450 mg/kg between 3 and 25 days after OA induction. The animals were clinically evaluated every 7 days, euthanized at 29 days, and the liver, spleen, kidney and knee collected for histopathological analysis. The chemical composition of EHA was identified by HPLC-MS and the identified compounds submitted to molecular docking study. The results showed that the extract promoted cyclooxygenase inhibition and produced significant improvements in disability, motor activity, hyperalgesia, and OA-induced allodynia parameters, in addition to improvements in the radiological condition of the knees (but not observed in the histopathological study). Chemically the extract is rich in flavonoids. Among them, we evidence that amentoflavone showed very favorable interactions with the enzyme COX-2 in the in silico analysis. Thus, it is concluded that A. chica has important analgesic properties for the treatment of OA.
Collapse
Affiliation(s)
- Cleydlenne Costa Vasconcelos
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA 65085-580, Brazil.
| | - Alberto Jorge Oliveira Lopes
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA 65085-580, Brazil.
| | - Emerson Lucas Frazão Sousa
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA 65085-580, Brazil.
| | - Darleno Sousa Camelo
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA 65085-580, Brazil.
| | | | | | - Gyl Eanes Barros Silva
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA 65085-580, Brazil.
| | - João Batista Santos Garcia
- Biological and Health Sciences Center, Federal University of Maranhão, Av. dos Portugueses 1966, São Luís, MA 65085-580, Brazil.
| | | |
Collapse
|
11
|
Rodrigues TA, de Oliveira Freire A, Carvalho HCO, Silva GEB, Vasconcelos JW, Guerra RNM, de Sousa Cartágenes MDS, Garcia JBS. Prophylactic and Therapeutic Use of Strontium Ranelate Reduces the Progression of Experimental Osteoarthritis. Front Pharmacol 2018; 9:975. [PMID: 30283333 PMCID: PMC6157419 DOI: 10.3389/fphar.2018.00975] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2018] [Accepted: 08/08/2018] [Indexed: 02/04/2023] Open
Abstract
Introduction: Strontium ranelate (SrRan) has the potential to interfere in the progression of osteoarthritis (OA), multifactorial disease associated with mechanical problems and articular inflammatory changes. Objectives: This study aimed to test the effects of prophylactic and therapeutic use of SrRan on clinical parameters of pain, the inflammatory process, and degradation of the articular cartilage. Methods: This was an experimental study, using a model of knee OA induced by intra-articular injection of monoiodoacetate. Thirty Wistar rats were divided into five groups and treated as indicated: control, without intervention; prophylactic, received SrRan at a daily oral dose of 250 mg/kg for 28 days before OA induction; SrRan treatments, administered 250 or 500 mg/kg/day for 28 days after the induction; and model control, received saline solution after the induction. Behavioral tests (joint incapacity, mechanical hyperalgesia, tactile sensitivity, and forced ambulation), histological evaluation of articular cartilage, and determination of inflammatory cytokines in the synovial fluid (interleukin [IL]-6, IL-10, tumor necrosis factor [TNF]-α, and interferon [INF]-γ) were performed. Results: Both prophylactic and therapeutic treatments improved the articular discomfort. A prophylactic dose of 500 mg/kg/day also improved mechanical hyperalgesia and the same dose was beneficial on tactile sensitivity. SrRan did not improve ambulation. Levels of IL-6, IL-10, TNF-α, and IFN-γ in SrRan-treated groups with OA were not significantly different compared with those in the normal control animals. The histopathological evaluation showed less articular damage in the SrRan-treated and control groups compared to the saline-treated group. Conclusion: The prophylactic and therapeutic administration of SrRan was associated with improved behavioral patterns of pain, especially joint discomfort. SrRan administration mitigated histological changes in the articular cartilage and reduced the inflammatory process, which beneficially reduced the progression of OA in the experimental model studied.
Collapse
Affiliation(s)
- Thiago A. Rodrigues
- Centro de Ciências Biológicas e da Saúde, Universidade Federal do Maranhão, São Luís, Brazil
| | | | | | | | | | | | | | | |
Collapse
|